共有 50 笔近期内部人交易记录记录，涉及 Virpax Pharmaceuticals, Inc. (VRPX), 包括 38 笔买入 和 3 笔卖出. 内部人买入总额为 $1.98M 内部人卖出总额为 $333.22K.
近期活跃的重要内部人包括 Panis Jaydriane, Randhawa Esha, Chaudhry Usama. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — VRPX
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-12-17 |
Panis Jaydriane |
Director |
未知 |
- |
- |
- |
- |
| 2024-11-19 |
Randhawa Esha |
Director |
未知 |
- |
- |
- |
- |
| 2024-11-18 |
Chaudhry Usama |
Officer |
未知 |
- |
- |
- |
- |
| 2024-07-05 |
Herman Gary L |
Director |
未知 |
- |
- |
- |
- |
| 2024-07-05 |
Herman Gary L |
Director |
限制性股票授予 (RSU) |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Dhaliwal Jatinder |
Director |
未知 |
- |
- |
- |
- |
| 2024-07-05 |
Dhaliwal Jatinder |
Director |
限制性股票授予 (RSU) |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Field Katharyn |
Director |
未知 |
- |
- |
- |
- |
| 2024-07-05 |
Field Katharyn |
Director |
限制性股票授予 (RSU) |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Su Judy |
Director |
未知 |
- |
- |
- |
- |
| 2024-01-29 |
Bruce Gerald W |
Chief Executive Officer |
限制性股票授予 (RSU) |
125,000 |
$0.32 |
$39.73K |
125,000 |
| 2024-01-29 |
Shah Vinay |
Chief Financial Officer |
限制性股票授予 (RSU) |
112,000 |
$0.32 |
$35.59K |
112,000 |
| 2024-01-29 |
Singh Vanila |
Director |
限制性股票授予 (RSU) |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Jambulingam Thani |
Director |
限制性股票授予 (RSU) |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Floyd Eric |
Director |
限制性股票授予 (RSU) |
45,000 |
$0.32 |
$14.3K |
45,000 |
| 2024-01-29 |
Sendrow Jerrold |
Director |
限制性股票授予 (RSU) |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Dubin Michael F |
Director |
限制性股票授予 (RSU) |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Ruskin Barbara |
Director |
限制性股票授予 (RSU) |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Mathias Sheila |
Chief Scientific Officer |
限制性股票授予 (RSU) |
112,000 |
$0.32 |
$35.59K |
112,000 |
| 2024-01-25 |
Mathias Sheila |
Chief Scientific Officer |
处置 |
112,000 |
$0.79 |
$88.48K |
- |
| 2023-06-20 |
Shah Vinay |
Chief Financial Officer |
限制性股票授予 (RSU) |
100,000 |
$0.99 |
$99K |
100,000 |
| 2023-06-20 |
Shah Vinay |
Officer |
未知 |
- |
- |
- |
- |
| 2023-06-20 |
Shah Vinay |
Chief Financial Officer |
限制性股票授予 (RSU) |
100,000 |
$0.99 |
$99K |
100,000 |
| 2023-04-24 |
Bruce Gerald W |
Director |
限制性股票授予 (RSU) |
100,000 |
$0.73 |
$73K |
100,000 |
| 2023-03-24 |
Ruskin Barbara |
Director |
未知 |
- |
- |
- |
- |
| 2023-03-24 |
Ruskin Barbara |
Director |
限制性股票授予 (RSU) |
25,000 |
$0.84 |
$20.91K |
25,000 |
| 2023-01-31 |
Mathias Sheila |
Chief Scientific Officer |
处置 |
60,676 |
$2.13 |
$129.24K |
- |
| 2023-01-25 |
Chipman Christopher Michael |
Chief Financial Officer |
限制性股票授予 (RSU) |
112,000 |
- |
- |
112,000 |
| 2023-01-25 |
Gudin Jeffrey |
Chief Medical Officer |
限制性股票授予 (RSU) |
50,000 |
- |
- |
50,000 |
| 2023-01-25 |
Mack Anthony P. |
Chief Executive Officer |
限制性股票授予 (RSU) |
125,000 |
- |
- |
125,000 |
| 2023-01-25 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
限制性股票授予 (RSU) |
125,000 |
$0.87 |
$108.38K |
125,000 |
| 2023-01-01 |
Singh Vanila |
Director |
限制性股票授予 (RSU) |
15,000 |
- |
- |
15,000 |
| 2023-01-01 |
Jambulingam Thani |
Director |
限制性股票授予 (RSU) |
40,000 |
- |
- |
40,000 |
| 2023-01-01 |
Floyd Eric |
Director |
限制性股票授予 (RSU) |
45,000 |
- |
- |
45,000 |
| 2023-01-01 |
Sendrow Jerrold |
Director |
限制性股票授予 (RSU) |
35,000 |
- |
- |
35,000 |
| 2023-01-01 |
Dubin Michael F |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
20,000 |
| 2022-05-24 |
Sendrow Jerrold |
Director |
知情买入 |
4,500 |
$1.29 |
$5.81K |
9,006 |
| 2022-05-18 |
Floyd Eric |
Director |
知情买入 |
4,479 |
$1.36 |
$6.11K |
8,018 |
| 2022-05-18 |
Mack Anthony P. |
Chief Executive Officer |
知情买入 |
75,750 |
$1.34 |
$101.51K |
252,562 |
| 2022-04-25 |
Bruce Gerald W |
Director |
限制性股票授予 (RSU) |
60,000 |
- |
- |
60,000 |
| 2022-04-07 |
Mathias Sheila |
Chief Scientific Officer |
处置 |
25,000 |
$4.62 |
$115.5K |
- |
| 2022-01-31 |
Chipman Christopher Michael |
Chief Financial Officer |
限制性股票授予 (RSU) |
100,000 |
$2.13 |
$213K |
100,000 |
| 2022-01-31 |
Gudin Jeffrey |
Chief Medical Officer |
限制性股票授予 (RSU) |
100,000 |
$2.13 |
$213K |
100,000 |
| 2022-01-31 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
限制性股票授予 (RSU) |
150,000 |
$2.34 |
$351K |
150,000 |
| 2022-01-31 |
Chipman Christopher Michael |
Chief Financial Officer |
限制性股票授予 (RSU) |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-31 |
Gudin Jeffrey |
Chief Medical Officer |
限制性股票授予 (RSU) |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-31 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
限制性股票授予 (RSU) |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-01 |
Jacob Gary S |
Director |
限制性股票授予 (RSU) |
12,091 |
$3.43 |
$41.47K |
12,091 |
| 2022-01-01 |
Singh Vanila |
Director |
限制性股票授予 (RSU) |
12,091 |
$3.43 |
$41.47K |
12,091 |
| 2022-01-01 |
Jambulingam Thani |
Director |
限制性股票授予 (RSU) |
14,113 |
$3.43 |
$48.41K |
14,113 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
